MétaCan
Menu
Back to cohort
Record W4390755692 · doi:10.1016/j.jaip.2024.01.009

Flex-IT! Applying “Platform Trials” Methodology to Immunotherapy for Food Allergy in Research and Clinical Practice

2024· article· en· W4390755692 on OpenAlexafffund
Douglas P. Mack, Julia Upton, Nandinee Patel, Paul Turner

Bibliographic record

VenueThe Journal of Allergy and Clinical Immunology In Practice · 2024
Typearticle
Languageen
FieldMedicine
TopicFood Allergy and Anaphylaxis Research
Canadian institutionsSickKids FoundationHospital for Sick ChildrenUniversity of TorontoMcMaster University
FundersNIHR Great Ormond Street Hospital Biomedical Research CentreNIHR Imperial Biomedical Research CentreMedical Research CouncilBausch HealthPfizerHospital for Sick ChildrenAstraZenecaAimmune TherapeuticsManchester Biomedical Research CentreFood Allergy CanadaAustralasian Society of Clinical Immunology and AllergyCanadian Institutes of Health ResearchImperial College LondonImperial College Healthcare NHS TrustNational Institute for Health and Care ResearchRegeneron PharmaceuticalsSanofi
KeywordsMedicineFLEXOral immunotherapyFood allergyImmunotherapyClinical trialAllergyClinical PracticeMedical physicsImmunologyFamily medicineInternal medicineImmune system

Abstract

fetched live from OpenAlex

There is an increasing trend in the management of food allergy toward active treatment using allergen immunotherapy (AIT). Although AIT is efficacious, treatment-related adverse events are common, particularly with oral immunotherapy in those with high levels of allergen-specific IgE sensitization. In clinical practice, these adverse events inevitably create challenges: clinicians and patients routinely face decisions whether to alter the dose itself, the frequency of dosing, and the pace of escalation, or indeed discontinue AIT altogether. Flexibility is therefore needed to adapt treatment, particularly in clinical practice, so that participants are "treated-to-target." For example, this may entail a significant change in the dosing protocol or even switching from one route of administration to another in response to frequent adverse events. We refer to this approach as flexible immunotherapy. However, there is little evidence to inform clinicians as to what changes to treatment are most likely to result in treatment success. Classical clinical trials rely, by necessity, on relatively rigid updosing protocols. To provide an evidence base to optimize AIT, the food allergy community should adopt adaptive platform trials, where a "master protocol" facilitates more efficient evaluation, including longer-term outcomes of multiple interventions. Within a single clinical trial, participants are able to switch between different treatment arms; interventions can be added or dropped without compromising the integrity of the trial. Developing platform trials for food AIT may initially be costly, but they represent a significant opportunity to grow the evidence base (with respect to both treatment outcomes and biomarker discovery) at scale. In addition, they could help understand longitudinal disease trajectories that are difficult to study in clinical trials for food allergy due to the time needed to demonstrate changes in efficacy. Finally, their adoption would achieve greater collaboration and consistency in approaches to proactive management of food allergy in routine clinical practice. As a community, we need to actively pursue this with funders and established research collaborations to deliver the very best outcomes for our patients and their families.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.333
metaresearch head score (Gemma)0.641
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.333
Threshold uncertainty score0.822

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.3330.641
Meta-epidemiology (narrow)0.0040.003
Meta-epidemiology (broad)0.0070.011
Bibliometrics0.0080.008
Science and technology studies0.0020.006
Scholarly communication0.0130.009
Open science0.0050.012
Research integrity0.0080.011
Insufficient payload (model declined to judge)0.1060.023

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.494
GPT teacher head0.599
Teacher spread0.105 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNon-randomized trial
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Allergy and Clinical Immunology In PracticeSame topicFood Allergy and Anaphylaxis ResearchFrench-language works237,207